Hap Trading, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 80,100 shares of RARE stock, worth $2.56 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,100Holding current value
$2.56 Million% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RARE
# of Institutions
362Shares Held
91.1MCall Options Held
3.65MPut Options Held
2.26M-
Vanguard Group Inc Valley Forge, PA10.1MShares$324 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$179 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.01MShares$128 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$126 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$92.2 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.24B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...